Home ••• Newswires by Industry • Countries • U.S. States • World Media Directory

Pharmaceutical Industry News ••• Topics • Countries • U.S. States

Colitis Drugs News Monitoring

Get by Email • RSS

Published on 16:26 GMT

FDA Grants Yuflyma Interchangeability Designation for Humira

The FDA designated adalimumab-aaty (Yuflyma) as an interchangeable biosimilar to adalimumab (Humira). Adalimumab-aaty was approved in May 2023 as a high-concentration (100 mg/mL), citrate-free biosimilar formulation.1,2 "With this new designation, …

Source: Drug Topics - Neutral
Published on 19:41 GMT

FDA Grants Interchangeable Designation to Yuflyma for Humira

The FDA has designated Yuflyma (Adalimumab-aaty; Celltrion, Inc.) as an interchangeable biosimilar to adalimumab (Humira; AbbVie). The biosimilar was approved by the FDA in May 2023 as a high-concentration (100 mg/mL) and citrate-free formulation of …

Source: Pharmacy Times - Neutral
Published on 06:45 GMT

Development and Validation of Predictive Models for Inflammatory Bowel Disease Diagnosis: A Machine Learning and ...

Introduction Inflammatory bowel disease (IBD) is a chronic, incurable gastrointestinal condition that primarily includes Crohn’s disease (CD) and ulcerative colitis (UC).1 UC primarily affects the colon, with common symptoms including rectal bleeding or …

Source: Dove Medical Press - Neutral
Published on 01:31 GMT

U.S. FDA grants interchangeable designation to YUFLYMA® (adalimumab-aaty), Celltrion’s biosimilar to Humira® (adalimumab)...

YUFLYMA® (adalimumab-aaty) is a high-concentration (100mg/mL) and citrate-free formulation of Humira® (adalimumab) biosimilar, that is now interchangeable [1] Interchangeable designation of YUFLYMA® is supported by positive data from the Phase III …

Source: The AI Journal - Pending
Published on Apr 14, 2025

Studies identify promising new treatments for ulcerative colitis

According to the National Institutes of Health, between 600,000 and 900,000 Americans have ulcerative colitis, a chronic inflammatory disease of the large intestine. While treatments for the disease exist, not all patients respond to them. The results of …

Source: U Chicago News - Illinois - Neutral
Published on Apr 14, 2025

FDA Approves Opdivo® Plus Yervoy® for Unresectable or Metastatic Hepatocellular Carcinoma

Bristol Myers Squibb (announced that the FDA approved Opdivo® (nivolumab) plus Yervoy® (ipilimumab) as a first-line treatment for adult patients with unresectable or metastatic hepatocellular carcinoma (HCC), the most common primary liver cancer. This …

Source: American Pharmaceutical Review - Neutral
Published on Apr 14, 2025

More Is Not Always Better: Innovations in Oncology Treatment and Diagnostics

Oncology has seen waves of innovation in diagnostics, treatment, and patient management in recent years. However, with novel options comes a need for more nuanced decision-making for providers and patients. Speakers at an Institute for Value-Based Medicine …

Source: The American Journal of Managed Care - Neutral
Published on Apr 14, 2025

Biologic Overlap During Medication Switches Is Safe in IBD

TOPLINE: Among patients with inflammatory bowel disease (IBD), overlapping biologic therapy was common during medication switches and was not associated with a higher risk for infection than nonoverlapping biologic therapy, indicating that shorter washout …

Source: Medscape - Neutral
Published on Apr 14, 2025

Celltrion’s Yuflyma secures FDA interchangeability designation with Humira in US

Celltrion said it has received U.S. FDA approval for an interchangeability designation between Yuflyma (ingredient: adalimumab), its biosimilar for autoimmune diseases, and the reference product Humira. AbbVie's Humira, the original medicine, is …

Source: Korea Biomedical Review - Neutral
Published on 13:25 GMT

Biocon Biologics inks licence agreement with Regeneron to commercialise Yesafili

Biocon Biologics Ltd (BBL), the biosimilars company and subsidiary of Biocon Ltd, has announced a licence agreement with Regeneron to commercialise Yesafili, a drug used to treat ophthalmological conditions. The agreement allows the company to launch the …

Source: The Hindu Business Line - Neutral
Published on 14:11 GMT

Antibody-Based Therapeutics in Small Cell Lung Cancer: A Narrative Review

Introduction Small-cell lung cancer (SCLC) is the most aggressive form of lung cancer. It has an incidence of 1–5 cases per 100,000 people per year and accounts for 10–15% of all lung cancers.1 The risk of developing SCLC is higher in older men (more than …

Source: Dove Medical Press - Neutral
Published on Apr 14, 2025

Latest Biosimilar Deals Signal Growth Across Immunology, Oncology Markets

During the first quarter of 2025, pharmaceutical companies have taken charge to strengthen their biosimilar portfolios, announcing new deals and partnerships that are sure to provide patients across the immunology and oncology fields greater access to life …

Source: The Center for Biosimilars - Pending
Published on Apr 12, 2025

European Commission approves AbbVie’s RINVOQ® for treatment of Giant Cell Arteritis

NORTH CHICAGO- April 2025- AbbVie announced that the European Commission (EC) granted marketing authorization to RINVOQ® (upadacitinib; 15 mg, once daily) for the treatment of giant cell arteritis (GCA) in adult patients. RINVOQ is the first and only oral …

Source: MedEdge MEA - Pending
Published on Apr 14, 2025

Recognizing and Managing Bronchiectasis in IBD Patients

Photo Credit: freepik The following is a summary of “Bronchiectasis In Patients With Inflammatory Bowel Diseases – Prevalence, Predictors, And Clinical Characteristics,” published in the March 2025 issue of CHEST Journal by Freund et al. BE, a chronic and …

Source: Physician's Weekly - Neutral
Published on Apr 12, 2025

Bausch Health, Canada & pCPA sign LoI for public drug plan coverage of PrCABTREO for treatment of acne vulgaris

Bausch Health, Canada Inc, part of Bausch Health Companies Inc announced that it has signed a letter of intent with the pan-Canadian Pharmaceutical Alliance (pCPA) for Canadian public drug plan coverage for PrCABTREO (clindamycin phosphate, adapalene and …

Source: Pharmabiz.com - Neutral
Published on Apr 11, 2025

J&J reports analysis from Phase III trial of plaque psoriasis treatment

Johnson & Johnson (J&J) has reported data from the Phase III ICONIC-LEAD trial’s subgroup analysis evaluating icotrokinra in treating moderate-to-severe plaque psoriasis (PsO). The data revealed that adolescents who were administered the therapy …

Source: Clinical Trials Arena - Pending
Published on Apr 11, 2025

FDA Approves Nivolumab/Ipilimumab for Metastatic or Unresectable HCC

The FDA announced its approval of frontline nivolumab (Opdivo) plus ipilimumab (Yervoy) for use in adult patients with unresectable or metastatic hepatocellular carcinoma (HCC), according to an announcement from the agency.1 The approval is based on data …

Source: Oncology Nursing News - Pending
Published on Apr 11, 2025

Budget Impact Analysis Presented At IMKASID 2025 Shows Opportunity To Reduce Budgetary Pressures And Improve Treatment ...

Total expected savings from ustekinumab biosimilars estimated to be €526M in Germany, the United Kingdom and Sweden over three years; annual saving per patient estimated to be €5,167, €709, and €3,388 in the respective countries The Samsung Bioepis and …

Source: Biosimilar Development - Pending
Published on Apr 11, 2025

The Future of GI Drug Delivery in Managing IBD

Innovative drug delivery systems are emerging as promising solutions to overcome the limitations of traditional formulations by enabling sustained and targeted drug release in the gastrointestinal (GI) tract, particularly for treating inflammatory bowel …

Source: The American Journal of Managed Care - Neutral

06 days 07:55:46

Featured Releases

Got News to Share? · Submit · See All

Published on April 15, 2025 - 11:19 GMT

Antiemetic Drugs Market Size to Reach 30.4B USD by 2035, Growing at a CAGR of 3.62% | Teva Pharmaceuticals

As per MRFR analysis, the Antiemetic Drugs Market Growth Size was estimated at 19.83 (USD Billion) in 2023. US, NY, UNITED STATES, April 15, 2025 /⁨EINPresswire.com⁩/ -- The global antiemetic drugs market is a vital component of the …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on April 15, 2025 - 15:00 GMT

Flottweg Features Separation Solutions for Pharmaceutical, Chemical & Fermentation Processes

Visit Flottweg at the Powder & Bulk Show to learn about technology used for hygienic separation for pharmaceutical and industrial biotechnology applications. ROSEMONT, IL, UNITED STATES, April 15, 2025 /⁨EINPresswire.com⁩/ -- There is an …

Distribution channels: Chemical Industry, Energy Industry ...

Published on April 15, 2025 - 09:08 GMT

Asthma Drugs Market Set to Grow at an Impressive CAGR of 3.67% Through 2035 | USD 60.5 Billion

Oral and injectable forms are expanding, especially for patients with severe asthma and those undergoing biologic treatments US, NY, UNITED STATES, April 15, 2025 /⁨EINPresswire.com⁩/ -- Global Asthma Drugs Market Set to Reach USD 60.5 Billion by …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on April 15, 2025 - 13:00 GMT

Artemis Factor Leads AI Round Table at Top Pharma & Biotech Conference: Where Strategy Meets Impact

PHILADELPHIA, PA, UNITED STATES, April 15, 2025 /⁨EINPresswire.com⁩/ -- Artemis Factor, a premier management consulting firm in the pharmaceutical/ biotech, healthcare, and life sciences sectors, is proud to announce it will lead a sponsored AI-Focused …

Distribution channels: Business & Economy, Chemical Industry ...

Published on April 15, 2025 - 17:03 GMT

The Gross Law Firm Notifies Actinium Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – ...

NEW YORK, April 15, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Actinium Pharmaceuticals, Inc. (NYSE: ATNM). Shareholders who purchased shares of ATNM during the class period listed are encouraged to contact …

Distribution channels: Law ...
Published on April 15, 2025 - 13:26 GMT

Er-Kim Announces Exclusive Distribution Agreement with Polaris Pharmaceuticals to Commercialize Pegargiminase (ADZODI) ...

ATHENS, Greece and SAN DIEGO, April 15, 2025 (GLOBE NEWSWIRE) -- Er-Kim Pharmaceuticals, an international company specializing in the commercialization of novel therapies for pharmaceutical and biopharmaceutical companies, today announced it has signed a …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on April 15, 2025 - 13:00 GMT

Scilex Holding Company Announces Approval of a New Drug Submission (NDS) from the Health Canada’s Pharmaceutical Drugs ...

ELYXYB® is a first-line treatment and the only FDA-approved, ready-to-use oral solution for the acute treatment of migraine, with or without aura, in adults.1 According to market data from 2018, it was found that migraine was more severe than other types …

Distribution channels:
Published on April 15, 2025 - 13:00 GMT

LiveWorld Releases First-Ever AI Brand Reputation Index for Leading Pharmaceutical Brands

CAMPBELL, Calif. and NEW YORK, April 15, 2025 (GLOBE NEWSWIRE) -- LiveWorld, Inc. (OTC Markets: LVWD), a pioneer in social-first digital engagement and integrated human-AI solutions, today released its inaugural AI Brand Reputation Index, providing …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Got news to share? Submit it now.

Load more pharmaceuticals news or search news using your own keywords. There are 803,555,114 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Pharmaceutical Industry News by Country

Pharmaceutical Industry News by U.S. State

Pharmaceutical Industry News Topics

Online News Publications

World News Report

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter

Create RSS Feed

NewsPlugin for WordPress

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire

Events

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 03/19/2025

World Media Directory

Healthcare & Pharmaceuticals Industry Press Releases

Got News to Share? · Submit · See All

Published on April 15, 2025 - 19:42 GMT

Harris Dental Provides Partial Dentures for Local Patients in Cape Cod

Harris Dental Cape Cod Offers Partial Dentures for Local Patients BARNSTABLE, MA, UNITED STATES, April 15, 2025 /⁨EINPresswire.com⁩/ -- Harris Dental is proud to offer high-quality partial dentures for patients looking to restore their smiles and improve …

Distribution channels: Beauty & Hair Care, Culture, Society & Lifestyle ...
Published on April 15, 2025 - 19:39 GMT

Harris Dental Offers White Spot Removal for Local Patients in Cape Cod

Cape Cod Patients Can Now Get White Spot Removal at Harris Dental BARNSTABLE, MA, UNITED STATES, April 15, 2025 /⁨EINPresswire.com⁩/ -- Patients struggling with noticeable white spots on their teeth now have a non-invasive solution, thanks to …

Distribution channels: Beauty & Hair Care, Consumer Goods ...
Published on April 15, 2025 - 18:57 GMT

3rd Annual Louisiana Cann Festival Returns May 17 with International Artist Sister Nancy

The full-day plant medicine festival takes over Downtown Baton Rouge with music, education, and culture. BATON ROUGE, LA, UNITED STATES, April 15, 2025 /⁨EINPresswire.com⁩/ -- The Louisiana Cann Festival (LCFest) returns to Downtown Baton Rouge …

Distribution channels: Companies, Conferences & Trade Fairs ...
Published on April 15, 2025 - 18:36 GMT

CureMetrix Expands cmAngio With FDA Clearance for Version 1.6, Now Validated on Hologic & GE Platforms

CureMetrix expands FDA clearance for cmAngio to include GE Healthcare, increasing access for more women to AI-powered BAC detection in mammography. SAN DIEGO, CA, UNITED STATES, April 15, 2025 /⁨EINPresswire.com⁩/ -- CureMetrix®, a global leader …

Distribution channels: Healthcare & Pharmaceuticals Industry, IT Industry ...
Published on April 15, 2025 - 17:29 GMT

Touched by Type 1 Short Film Hannah’s Story Nominated for 2025 People’s Telly Award

ORLANDO, FL, UNITED STATES, April 15, 2025 /⁨EINPresswire.com⁩/ -- Hannah’s Story: Strength, Hope & Awareness, a short film produced by Touched by Type 1, has been officially nominated for a 2025 People’s Telly Award in the Film & Shorts …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on April 15, 2025 - 17:17 GMT

Gary S. Williams of Williams Asset Management Recognized in Forbes' Best-In-State Wealth Advisors List for 2025

COLUMBIA , MD, UNITED STATES, April 15, 2025 /⁨EINPresswire.com⁩/ -- Williams Asset Management, an independent investment and financial planning firm in Howard County, Maryland, is proud to announce that its CEO and President, Gary S. Williams, CFP …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
Published on April 15, 2025 - 17:16 GMT

Canadian Colon Cancer Patient Turns to Mexico After Healthcare System Fails Her

Canadian Colon Cancer Patient Finds Life-Changing Treatment in Mexico After Facing Delays at Home. Tijuana’s Integrative Approach Offers New Hope. TIJUANA, MEXICO, April 14, 2025 /⁨EINPresswire.com⁩/ -- When Michelin Tunor from Nova Scotia was …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on April 15, 2025 - 17:13 GMT

D.A.W. Systems Appoints John Ketcham as Chief Revenue Officer to Accelerate Growth and Expansion

ALBANY, NY, UNITED STATES, April 15, 2025 /⁨EINPresswire.com⁩/ -- D.A.W. Systems, Inc. (www.dawsystems.com), developer of the ScriptSure E-Prescribing, announces the appointment of John Ketcham as its new Chief Revenue Officer (CRO). In this role, …

Distribution channels: Business & Economy, Companies ...
Published on April 15, 2025 - 17:10 GMT

Salve Strengthens North American Presence with Strategic Expansion to Support Fertility Market

NEW YORK, NY, UNITED STATES, April 15, 2025 /⁨EINPresswire.com⁩/ -- Salve; a digital health platform specializing in delivering a world class digital experience for patients going through fertility treatments, helping patients and clinics alike to …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on April 15, 2025 - 16:37 GMT

Dr. Donald B. Brockley Celebrates 50 Years of Smiles: Marking Half a Century of Dental Excellence in Butler, PA

Honoring five decades of clinical innovation, compassionate care, and community service by one of Butler, PA’s most trusted and respected dental professionals. BUTLER, PA, UNITED STATES, April 15, 2025 /⁨EINPresswire.com⁩/ -- In a remarkable …

Distribution channels: Business & Economy, Consumer Goods ...
Published on April 15, 2025 - 16:33 GMT

Centre Technologies Appoints CFO to Support Strategic Growth Across Texas and Oklahoma

Chris McMahan joins the rapidly growing MSP, Centre Technologies, as CFO. This addition continues to boost Centre's already prominent growth across TX and OK. HOUSTON, TX, UNITED STATES, April 15, 2025 /⁨EINPresswire.com⁩/ -- Centre …

Distribution channels: Business & Economy, Energy Industry ...
Published on April 15, 2025 - 16:33 GMT

SPP Dental Partners Welcomes First Orthodontist, Expanding Support for Independent Practices

Dr. Daniel Hulme of Hulme Orthodontics Joins SPP Dental Partners, Enhancing Orthodontic Care While Empowering Private Practice Ownership. SANTA CRUZ, CA, UNITED STATES, April 15, 2025 /⁨EINPresswire.com⁩/ -- SPP Dental Partners, a leading Dental …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on April 15, 2025 - 16:15 GMT

Kansas City University College of Osteopathic Medicine launches behavioral health and leadership tracks

KANSAS CITY, MO, UNITED STATES, April 15, 2025 /⁨EINPresswire.com⁩/ -- In an ever-evolving health care landscape, Kansas City University College of Osteopathic Medicine is leading the way with two innovative tracks in behavioral health and …

Distribution channels: Business & Economy, Education ...
Published on April 15, 2025 - 16:07 GMT

Lap of Love Now Offers In-Home, End-of-Life Veterinary Services in North Shore, MA

Lap of Love is the nation's leading provider of in-home, veterinary hospice, euthanasia, telehospice, and pet loss support services. NORTH SHORE, MA, UNITED STATES, April 15, 2025 /⁨EINPresswire.com⁩/ -- Lap of Love Veterinary Hospice & In-Home …

Distribution channels: Companies, Consumer Goods ...
Published on April 15, 2025 - 16:05 GMT

Jacqueline Hess Joins Immunophotonics Board of Directors

ST. LOUIS, MO, UNITED STATES, April 15, 2025 /⁨EINPresswire.com⁩/ -- Immunophotonics, Inc., a clinical-stage biotech company focused on immuno-oncology, is pleased to announce the appointment of Jacqueline Hess to its Board of Directors. With over …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
Published on April 15, 2025 - 16:00 GMT

Patients Medical Expands Functional IV Therapy Services in NYC. Supports Immune Health, Fatigue, and Nutrient Deficiency

The expanded offerings now include personalized vitamin IV drips, nutrient IV therapy, and advanced NAD+ and glutathione infusions, under physicians care. NEW YORK, NY, UNITED STATES, April 15, 2025 /⁨EINPresswire.com⁩/ -- Patients Medical Expands …

Distribution channels: Business & Economy, Culture, Society & Lifestyle ...
Published on April 15, 2025 - 16:00 GMT

Next Day Access Michiana: New Franchise Location

Next Day Access, a leading provider of accessibility solutions, is expanding its Indiana and Michigan outreach with the opening of Next Day Access Michiana. SOUTH BEND, IN, UNITED STATES, April 15, 2025 /⁨EINPresswire.com⁩/ -- Next Day Access, a …

Distribution channels: Business & Economy, Companies ...
Published on April 15, 2025 - 16:00 GMT

BeneLynk Earns VETS Indexes 5 Star Employer Award for 2025

SUNRISE, FL, UNITED STATES, April 15, 2025 /⁨EINPresswire.com⁩/ -- BeneLynk, a national provider of social care solutions for managed care plans, proudly announces its recognition as a 2025 VETS Indexes 5 Star Employer. This marks the fifth …

Distribution channels: Business & Economy, Companies ...
Published on April 15, 2025 - 15:55 GMT

A Story of Survival, A Message of Hope: Mother Pens Memoir After Son’s Triumph Over Rare Heart Condition

‘HEARTBEAT OF HOPE’ – A MEMOIR OF FAITH, FIGHT, AND A MOTHER’S UNBREAKABLE LOVE Explores the Depth of Maternal Strength and the Power of Hope Against All Odds LONDON, LONDON, UNITED KINGDOM, April 15, 2025 /⁨EINPresswire.com⁩/ -- When the heart of …

Distribution channels: Book Publishing Industry, Culture, Society & Lifestyle ...
Published on April 15, 2025 - 15:44 GMT

The Brookbush Institute Publishes NEW Glossary Updates: 'Plyometric and Amortization Phase'

The Brookbush Institute continues to enhance education with new courses, a modern glossary, an AI Tutor, and a client program generator. NEW YORK, NY, UNITED STATES, April 15, 2025 /⁨EINPresswire.com⁩/ -- Excerpt from the glossary term: Plyometric …

Distribution channels: Education, Healthcare & Pharmaceuticals Industry ...